Skip to content
BIOSerenity logo — Where AI meets brainwaves to redefine patient care.
AI-assis...

BIOSerenity

Where AI meets brainwaves to redefine patient care. AI-assisted Electrophysiology Diagnostics

Founded 2014 France France 271 employees Venture round Total: $107.12M Health Care, Insurtech +1

General Information

Company Name BIOSerenity
Founded Year 2014
Location France France
Founders / Decision Makers
Team member
Employees 271
Industries Health Care, Insurtech, Medical Devices
Funding Stage Venture round
Business Model B2B, Platform, SaaS
Revenue Model Product Sales, Subscription, Usage Based
Offices as of Aug 2026
Paris, France
Social

BounceWatch is an independent company data service, not affiliated with BIOSerenity. To contact BIOSerenity, visit bioserenity.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BIOSerenity compare?

A PDF of BIOSerenity and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BIOSerenity soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BIOSerenity

BIOSerenity, founded in 2014 and headquartered in Paris, France, offers groundbreaking solutions within the Health Care, Insurtech, and Medical Devices industries. Their slogan, "Connected & integrated neurosciences. Brain monitoring & remote diagnostic," succinctly captures the company's mission to advance the monitoring and diagnosis of patients with chronic neurological, sleep, and cardiovascular conditions.

Utilizing a suite of physiological sensors, an IoT platform, apps, and A.I., BIOSerenity identifies digital biomarkers, partnering with over 200 hospitals across Europe to facilitate the diagnosis of more than 100,000 patients annually.

In its latest round of funding, the company secured a €24.00M investment from Jolt Capital on 13 November 2023. This injection of capital denotes confidence in BIOSerenity's potential, bolstering their innovative approach towards revolutionizing patient care in chronic disease management.

Business keywords: Connected Medical Solutions, Chronic Disease Diagnostics, Neurology, Sleep Disorders, Cardiology, Physiological Sensors, IoT Platform, Digital Biomarkers, AI in Healthcare, Remote Diagnostics, Smart Clothing, Mobile Diagnostics, EEG, Polysomnography, Research Collaboration

Services & Products

EEG Monitoring and Diagnostics
Sleep Disorder Management
AI and Software Solutions for Hospitals
Connected EEG Devices

Target Customers

Hospitals Medical Facilities Specialist Doctors Healthcare Providers Patients with Neurological Disorders

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €24.00M 1
Jolt Capital
13 Nov 2023
Corporate Round Undisclosed 1
SCOR Global P&C
17 Feb 2022
Corporate Round Undisclosed 1
SCOR Global P&C
05 Nov 2019
Series B €65.00M 4
Bpifrance, IDInvest Partners +2
19 Jun 2019
Series A €15.00M 4
Bpifrance, IDInvest Partners +2
20 Sep 2017
Seed Round €3.00M 2
IDInvest Partners, Kurma Partners
19 Nov 2015
Pre Seed Round €120.00K 1
WILCO
10 Sep 2014

BIOSerenity Alternatives & Competitors

View All Alternatives
BIOSerenity vs

Improving lives by simplifying remote care | Inc. 5000 #55 in the US, #2 in Boston Metro, #1 in NH a...

Series A
44 employees
Health Care, Information Technology
BIOSerenity vs
VivoSense, Inc.
VivoSense, Inc. United States

Advancing clinical trials research and healthcare delivery with analytics & AI for all wearable sens...

Grant
42 employees
Biotechnology, Health Care
BIOSerenity vs

Disruptive technology for rapid non-invasive, real-time diagnosis

Grant
7 employees
Big Data, Health Care

FAQ About BIOSerenity

Where AI meets brainwaves to redefine patient care. AI-assisted Electrophysiology Diagnostics
BIOSerenity was founded in 2014.
BIOSerenity is headquartered in France. As of Aug 2026, it also has offices in Paris, France.
BIOSerenity operates in Health Care, Insurtech and Medical Devices. Its work centres on Connected Medical Solutions, Chronic Disease Diagnostics, Neurology and Sleep Disorders. Its customers include Hospitals, Medical Facilities and Specialist Doctors.
BIOSerenity has a B2B, Platform and SaaS business model. Its revenue comes from Product Sales, Subscription and Usage Based.
BIOSerenity has approximately 271 employees.
BIOSerenity has completed 7 funding rounds, raising a total of $107.12M. The latest funding stage is Venture round.
BIOSerenity offers: EEG Monitoring and Diagnostics, Sleep Disorder Management, AI and Software Solutions for Hospitals, Connected EEG Devices.
Top alternatives and competitors to BIOSerenity include Tenovi, an Inc. 5000 Company, VivoSense, Inc., NaNose Medical, Medikabazaar, Onera Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOSerenity and Tenovi, an Inc. 5000 Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BIOSerenity, https://bouncewatch.com/company/bioserenity, updated 2 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout